ArticleBMC infectious diseases2020

Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events.

Ralph Rogers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.